Is biologic treatment of hidradenitis suppurativa during the COVID-19 pandemic different from psoriasis biologic treatment?

J Dermatolog Treat. 2022 Feb;33(1):599. doi: 10.1080/09546634.2020.1771256. Epub 2020 Jun 19.
No abstract available

Publication types

  • Letter

MeSH terms

  • Biological Products* / therapeutic use
  • COVID-19*
  • Hidradenitis Suppurativa* / drug therapy
  • Hidradenitis Suppurativa* / epidemiology
  • Humans
  • Pandemics
  • Psoriasis* / drug therapy
  • Psoriasis* / epidemiology
  • SARS-CoV-2

Substances

  • Biological Products